This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
The long-acting formulation of fluticasone propionate utilizing extended-release technology may offer a longer duration of pain relief than vehicle control in patients with knee osteoarthritis.
Medscape Medical News